Pharmacokinetics and safety of pegylated recombinant human granulocyte colony‐stimulating factor in children with acute leukaemia-Reference-Cited by-同舟云学术

Pharmacokinetics and safety of pegylated recombinant human granulocyte colony‐stimulating factor in children with acute leukaemia

Published:2021-02-23 Issue:8 Volume:87 Page:3292-3300
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Liu Xi‐Ting¹,Zhao Yan‐Xia²,Jia Guang‐Wei³,Yang Fan¹,Zhang Chuan‐Zhou⁴,Han Bing⁴,Dai Jian‐Hua⁵,Han Yue‐Qin⁵,Tang Bo‐Hao¹,Yang Xin‐Mei⁶,Shi Hai‐Yan⁶,Zhou Yue¹,Sui Zhong‐Guo⁴,Chen Jian‐Zhong³,Anker Johannes N.⁷⁸⁹,Zhao Wei¹⁶^ORCID

Affiliation:

1. Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine Shandong University Jinan China

2. Department of Pediatric Hematology The Affiliated Hospital of Qingdao University Qingdao China

3. Key Laboratory of Clinical Pharmacology Liaocheng People's Hospital Liaocheng China

4. Department of Pharmacy The Affiliated Hospital of Qingdao University Qingdao China

5. Department of Pediatrics Liaocheng People's Hospital Liaocheng China

6. Department of Pharmacy, Clinical Trial Center The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Jinan China

7. Division of Clinical Pharmacology Children's National Medical Center Washington District of Columbia USA

8. Departments of Pediatrics, Pharmacology & Physiology, Genomics & Precision Medicine the George Washington University School of Medicine and Health Sciences Washington District of Columbia USA

9. Department of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel University of Basel Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14750

Reference35 articles.

1. Proposed biosimilar pegfilgrastim shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects

2. Epidemiology of Febrile Neutropenia

3. 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

4. Pharmacokinetic/Pharmacodynamic Modeling of Pegfilgrastim in Healthy Subjects

5. G‐CSF: function and modes of action;Basu S;Int J Mol Med,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study;Frontiers in Pharmacology;2024-07-17

2. A multicenter phase II trial of primary prophylactic PEG‐rhG‐CSF in pediatric patients with solid tumors and non‐Hodgkin lymphoma after chemotherapy: An interim analysis;Cancer Medicine;2023-05-15

3. Progress of Clinical Application of Pegylated Recombinant Human Granulocyte-Colony Stimulating Factors and Its Effect on Immune Status;Advances in Clinical Medicine;2022